Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.

Expert opinion on investigational drugs - 1 Feb 2008

Michals-Matalon Kimberlee

Abstract excerpt

Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4) is being introduced in the US for treatment of phenylketonuria (PKU). This compound has been in use in Europe to treat mild forms of PKU. Tetrahydrobiopterin is the cofactor in the hydroxylation reaction of the three aromatic amino acids phenylalanine, tyrosine and tryptophan. It is also involved in other reactions, which are not the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopterins
Share to Clinical Trials as Topic
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenylalanine

Share to Phenylketonurias

Source

Identifiers

PMID: 18230057
DOI: 10.1517/13543784.17.2.245

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sapropterin dihydrochloride, 6-R-L-erythro-5,6,7,8-tetrahydrobiopterin, in the treatment of phenylketonuria.PMID 18230057Read ↗

Sapropterin dihydrochloride for the treatment of hyperphenylalaninemias.Semantic proximity Read ↗

An Overview of Traditional and Novel Therapeutic Options for the Management of Phenylketonuria.Semantic proximity Read ↗

Guide for diagnosis and treatment of hyperphenylalaninemia.Semantic proximity Read ↗

Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria.Semantic proximity Read ↗

Nutritional and Therapeutic Strategies in Paediatric Phenylketonuria: A Narrative Literature ReviewSemantic proximity Read ↗

The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency.Semantic proximity Read ↗

Response of patients with phenylketonuria in the US to tetrahydrobiopterin.Semantic proximity Read ↗

Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.Semantic proximity Read ↗

Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies.Semantic proximity Read ↗

5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.Semantic proximity Read ↗

Potential therapeutic applications of tetrahydrobiopterin: from inherited hyperphenylalaninemia to mitochondrial diseases.Semantic proximity Read ↗

BH4-deficient hyperphenylalaninemia in Russia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.